Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Approved For Marketing No phase listed Expanded access

Copper Histidinate Treatment for Menkes Disease

ClinicalTrials.gov ID: NCT04074512

Public ClinicalTrials.gov record NCT04074512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 10:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This expanded access protocol provides subcutaneous copper histidinate for Menkes disease patients under 6 years of age.

Study identification

NCT ID
NCT04074512
Recruitment status
Approved For Marketing
Study type
Expanded access
Phase
Not listed
Lead sponsor
Sentynl Therapeutics, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
0 Years to 6 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Mar 2, 2026

United States locations

U.S. sites
20
U.S. states
17
U.S. cities
20
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016 —
University of California Davis Medical Center Sacramento California 95817 —
Rady Children's Hospital San Diego California 92123 —
Children's Hospital Colorado Aurora Colorado 80045 —
Connecticut Children's Medical Center Hartford Connecticut 06106 —
Memorial Healthcare Systems Hollywood Florida 33021 —
Johns Hopkins All Children's Hospital St. Petersburg Florida 33701 —
Emory University Atlanta Georgia 30322 —
Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
University of Iowa Stead Family Children's Hospital Iowa City Iowa 52242 —
Maine Medical Center Portland Maine 04102 —
Helen DeVos Children's Hospital Grand Rapids Michigan 49503 —
Shodair Children's Hospital Helena Montana 59601 —
Duke University Hospital Durham North Carolina 27710 —
Oregon Health & Science University Portland Oregon 97239 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
Monroe Carrell Jr. Children's Hospital at Vanderbilt University Medical Center Nashville Tennessee 37232 —
Cook Children's Health Care System Fort Worth Texas 76104 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04074512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04074512 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →